期刊文献+

齐拉西酮——新型非典型抗精神病药物应用研究 被引量:35

下载PDF
导出
出处 《重庆医学》 CAS CSCD 2007年第6期496-498,共3页 Chongqing medicine
  • 相关文献

参考文献15

  • 1Charles,Caley F,Chandra,et al.Ziprasidone:the fifth atypical antipsychotic[J].Ann Pharmacother,2002,36:839
  • 2Schmidt AW,Lebel LA,Howard HR Jr,et a1.Ziprasidone:a novel antipsychotic agent with aunique human receptor binding profile[J].Eur J Pharmacol,2001,425(3):197
  • 3苗国栋,马崔,杨德森.氯氮平和维思通治疗精神分裂症的比较[J].国外医学(精神病学分册),1998,25(4):214-217. 被引量:30
  • 4Brook S,Lucey JV,Gunn KP.for the ziprasidone IM S tudy Group.Intramuscular ziprasidone compared with Intramuscular haloperidol in the treatment of acute psychosis[J].J Clin Psychiatry,2000,61:933
  • 5李乐华,赵靖平,许秀峰,蒙华庆,宁洁.国产齐拉西酮与氟哌啶醇注射液治疗精神分裂症急性激越症状的对照研究[J].中华精神科杂志,2006,39(4):216-219. 被引量:51
  • 6王任昌,李乐华,赵一超.国产甲磺酸齐拉西酮与氟哌啶醇治疗精神分裂症急性激越症状 随机单盲双模拟平行对照[J].中国临床康复,2005,9(44):83-85. 被引量:9
  • 7Simpson GM,Glick ID,Weiden PJ,et al.Randomized,controlled,double-blind multicenter comparsion of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder[J].Am J Psychiatry,2004,161:1837
  • 8Allison DB,Mentore JL,Heo M,et a1.An tipsychotic-induced weight gain:a comprehensive research synthesis[J].Am J Psychiatry,1999,156:1686
  • 9American Diabetes Association,American Psychiatric Association,American Association of Clinical Endocrinologists,North American Association for the Study of Obesity:consensus development conference on antipsychotic drugs and obesity and diabetes[J].J Clin Psychiatry,2004,65:267
  • 10Stroup TS,Lieberman JA,Swartz MS,et al.Effectiveness of olanzapine,quetiapine,risperidone,and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic[J].Am J Psychiatry,2006,163:611

二级参考文献13

  • 1Miceli JJ, Anziano RJ, Robarge L, et al. The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.Br J Clin Pharmacol 2000;49 Suppl 1:65S-70S
  • 2Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular Ziprasidone 2mg versus 10mg in the short term management of agitated psychotic patients. J Clin Psychiatry 2001;62(1):12-8
  • 3Daniel DG, Potkin SG, Reeves KR, et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a doubleblind, randomized trial.Psychopharmacology (Berl) 2001;155(2):128-34
  • 4Brook S,Lucey JV,Gunn KP.Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M.Study Group.J Clin Psychiatry 2000;61(12):933-41
  • 5Potkin SG,Keck PE,Segal S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.J Clin Psychopharmacol 2005;25(4):301-10
  • 6Keck PE Jr, Reeves KR, Harrigan EP; et al.Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two doubleblind, placebo-controlled, multicenter studies.J Clin Psychopharmacol 2001;21(1):27-35
  • 7Wilner KD, Anziano R J, Johnson AC, et al. The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery. J Clin Ps ychopharmacol 2002;22(2):206-10
  • 8Miceli JJ,Anziano RJ,Robarge L,et al.The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.Br J Clin Pharmacol,2000,49 Suppl 1:65S-70S.
  • 9Lesem MD,Zajecka JM,Swift RH,et al.Intramuscular ziprasidone,2 mg versus 10 mg,in the short-term management of agitated psychotic patients.J Clin Psychiatry,2001,62:12-18.
  • 10Daniel DG,Potkin SG,Reeves KR,et al.Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis:a double-blind,randomized trial.Psychopharmacology (Berl),2001,155:128-134.

共引文献79

同被引文献216

引证文献35

二级引证文献188

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部